hostile bid

    By The Associated Press

    | 2:00AM 11/04/2010
    In a surprise decision by a government that has historically favored foreign investment, Canada has rejected a foreign takeover bid for Saskatchewan-based Potash Corp. Australian mining company BHP Billiton had offered $38.6 billion in what would have been the world's largest corporate acquisition this year.

    By Melly Alazraki

    | 8:30AM 10/08/2010
    There's a new plot twist in the takeover battle between French pharmaceutical giant Sanofi-Aventis and U.S. drugmaker Genzyme. A regulatory filing made by Genzyme on Thursday claims Sanofi may be willing to go much higher than its current $69 bid -- a claim the French company disputes.

    By Melly Alazraki

    | 6:55AM 10/04/2010
    After months of courting U.S. drugmaker Genzyme, French pharmaceutical company Sanofi-Aventis launched a hostile bid valued at approximately $18.5 billion, or $69 a share, for all outstanding shares of Genzyme common stock.

    By Dawn Kawamoto

    | 12:55PM 9/23/2010
    Avis Budget has increased its offer for Dollar Thrifty, firing the latest salvo in its bidding war for Dollar with archrival Hertz. It's a familiar pattern in the world of mergers and acquisitions, and the data shows that interlopers like Avis often a better chance of taking home the prize.

    By Dan Burrows

    | 4:53PM 9/08/2010
    Convenience-store chain 7-Eleven offered $2 billion to acquire competitor Casey's General Stores, topping a hostile bid by Canada's Alimentation Couche-Tard

    By David Schepp

    | 7:53AM 9/07/2010
    Air Products & Chemicals (APD) has raised its bid for Airgas (ARG) to $65.50 a share in an all-cash offer. The latest offer represents a 50% premium above Airgas' closing stock price on Feb. 4, the day prior to Air Products submitting its first acquisition plan, Air Products said Monday in a written statement.

    By Melly Alazraki

    | 2:49PM 8/25/2010
    Pharmaceutical giant Sanofi-Aventis is unwilling to pay more than $70 a share in its bid to buy biotech firm Genzyme, media outlets reported Wednesday. If a deal can't be reached, the French drugmaker may consider alternative takeover targets.

    By Sarah Weinman

    | 9:00PM 8/03/2010
    Think struggling book retailer Borders finished with layoffs in 2010? With four rounds of layoffs so far this year and no new ideas for a turnaround, don't be surprised if co-CEO Bennett Lebow pulls out his old 1980s playbook and makes a bid for, say, Barnes & Noble.